Novel nitroheterocyclic hypoxic markers for solid tumor: Synthesis and biological evaluation

  • Weiping Zhu
  • , Min Dai
  • , Yufang Xu*
  • , Xuhong Qian
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Based on the principle that the nitro-group can quench the fluorescence and can be reduced under hypoxic conditions, several novel nitroheterocyclic compounds without 2-nitroimidazole as potential hypoxic markers were prepared. Although they were synthesized from the same matrix, nitrosubstituted acenaphtho[1,2-b]quinoxaline, these compounds exhibited quite different fluorescence changes when they were differently nitrosubstituted. Their evaluation for imaging tumor hypoxia was carried out in V79 cells in vitro by Fluorescence Microplate Reader. After 3.5 h, the hypoxic-oxic fluorescence differential incubated with A1, A4, and A5 in V79 cells could reach 6, 9, and 11 times differential fluorescence between oxic and hypoxic cells separately, which are suitable for further evaluation as probes for hypoxic cells in tumors in vivo.

Original languageEnglish
Pages (from-to)3255-3260
Number of pages6
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number6
DOIs
StatePublished - 15 Mar 2008
Externally publishedYes

Keywords

  • Biological Evaluation
  • Hypoxic markers
  • Nitroheterocyclic
  • Synthesis

Fingerprint

Dive into the research topics of 'Novel nitroheterocyclic hypoxic markers for solid tumor: Synthesis and biological evaluation'. Together they form a unique fingerprint.

Cite this